Trimethroprim-sulfamethoxazole-induced dress syndrome
Síndrome DRESS por uso de trimetropin sulfametoxazol
Article Sidebar
PDF (Español (España))
FLIP
Main Article Content
Abstract
The term DRESS was introduced in 1996 to describe a drug reaction with eosinophilia, skin eruption and systemic symptoms. Potentially fatal drug reactions include three distinct entities: DRESS syndrome, acute generalized exanthem and Stevens-Johnson syndrome/toxic epidermal necrolysis. We report a case of DRESS syndrome in a female patient who attended Hospital de San José in Bogotá, for presenting a cutaneous reaction induced by trimethroprim/sulfamethoxazole. The physiopathology, diagnosis, clinical features and treatment, are outlined herein.
Keywords:
Downloads
Article Details
References
Callot V, Roujeau JC, Bagot M, Wechsler J, et al. Druginduced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol. 1996;132(11):1315–1321.
Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L. The DRESS Syndrome: A Literature Review. Am J Med. 2011;124(7):588-97. doi: 10.1016/j.amjmed.2011.01.017
Bellón T. Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances. Drug Saf. 2019;42(8):973-992. doi: 10.1007/s40264-019-00825-2
Choquet-Kastylevsky G, Intrator L, Chenal C, Bocquet H, Revuz J, Roujeau JC. Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Br J Dermatol. 1998;139(6):1026-32. doi: 10.1046/j.1365-2133.1998.02559.x
Lonjou C, Thomas L, Borot N, et al. A marker for Stevens- Johnson syndrome: ethnicity matters. Pharmacogenomics J. 2006;6(4):265–268. doi: 10.1038/sj.tpj.6500356
Kano Y, Shiohara T. Sequential reactivation of herpesvirus in drug-induced hypersensitivity syndrome. Acta Derm Venereal. 2004;84(6):484–485.
Quintero-Martínez DC, Flores-Arizmendi RA, Torres-Rodríguez L. Síndrome de DRESS asociado con carbamazepinaDRESS syndrome associated with carbamazepine. Bol Med Hosp Infant Mex. 2015;72(2):2-6. https://doi.org/10.1016/j.bmhimx.2015.03.007
Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, el at. The DRESS syndrome: a literature review. Am J Med. 2011;124(7): 588-597. doi: 10.1016/j.amjmed.2011.01.017
Husain Z, Reddy By, Schwartz RA. DRESS syndrome: Part 1 Clinical perspectives. Am Acad Dermatol 2013;68(5):693.e1-14. doi: 10.1016/j.jaad.2013.01.033
Peyriere H, Dereure O, Breton H, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol. 2006;155(2):422–428. doi: 10.1111/j.1365-2133.2006.07284.x
Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest. 1988;82(6):1826-32. doi: 10.1172/JCI113798
Cabrera H. Síndrome de hipersensibilidad a la sulfasalazina. Act Terap Dermatol. 2002;25:250.
TICSE AGUIRRE, Ray et al. Síndrome de hipersensibilidad por uso de Trimetoprim/sulfametoxazol: Reporte de un caso. Rev Med Hered. 2006;17(2):109-114.
Karpman E, Kurzrock EA. Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children. J Urol. 2004;172(2):448-453. doi: 10.1097/01.ju.0000130653.74548.d6